Murnauer Markenvertrieb GmbH, a portfolio company of Bregal Unternehmerkapital, has sold its pharmacy brand portfolio consisting of “DermaSel”, “Murnauer’s Bachblüten” as well as the CBD gels “Cannaren” and “Cannaxil” to Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mit beschränkter Haftung.
We acted as advisor to the sellers.
Apurano Pharmaceuticals successfully completed the realignment of its shareholder base including a private placement to secure its further expansion.
We initiated the transaction and advised Apurano Pharmaceuticals in its funding round.
Dermapharm has acquired Arkopharma SE from Montagu Private Equity LLP.
We acted as advisor to the buyer.
Dermazentrum sold a majority ownership stake in an Owners Buy-out to Halder.
We advised Dermazentrum and its founder.
Vitafy Brands and EVP Group have merged.
We acted as advisor to Vitafy Brands and its shareholders.
Dermapharm has acquired C3 – Cannabinoid Compound Company GmbH from Canopy Growth Corporation.
We acted as advisor to the buyer.
Wellster Healthtech successfully completed a USD 40m private placement led by a group of investors.
We advised and supported Wellster Healthtech in its funding round.
Oakley Capital has acquired WindStar Medical GmbH from ProSiebenSat.1 majority-owned NuCom Group.
We acted as advisor to the buyer.
Permira Beteiligungsberatung has acquired Neuraxpharm from Apax Partners.
We acted as advisor to the buyer.
We initiated the transaction and acted as advisor to Heinz-Peter Fichter and Apotal group.